Zimmer Biomet to acquire Paragon28 for $1.2bn.

Zimmer Biomet, a global medical technology provider, agreed to acquire Paragon28, a medical device company, for $1.2bn. "This proposed transaction further diversifies Zimmer Biomet's portfolio outside of core orthopedics and positions us well in one of the highest growth specialized segments in musculoskeletal care, while creating cross-selling opportunities in the rapidly growing ASC space," Ivan Tornos, Zimmer Biomet President and CEO.